_256_384.jpg){kind=logo}
Biotech | January 07, 2026
MetaVia’s DA-1726 shows breakthrough weight loss in Phase 1 trial
Fasting glucose improved by 12.3 mg/dL, while liver stiffness dropped 23.7%, signaling a direct hepatic benefit
Fasting glucose improved by 12.3 mg/dL, while liver stiffness dropped 23.7%, signaling a direct hepatic benefit
CIRRUS-HCM, an open-label, multi-part study, evaluates EDG-7500 in patients with obstructive and nonobstructive HCM
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Using a combination of blood and faecal samples, the service examines key biomarkers, including hereditary genetic status
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
76 of 180 long COVID-associated genes also linked to ME
Now a test that offers new precision in prostate cancer detection
The collaboration aims to make Alzheimer’s biomarker testing more accessible and less intimidating
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
